271 related articles for article (PubMed ID: 26078807)
1. Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?
Song K; Li Q; Yin XY; Lu Y; Liu CF; Hu LF
Oxid Med Cell Longev; 2015; 2015():458720. PubMed ID: 26078807
[TBL] [Abstract][Full Text] [Related]
2. The smell of renal protection against chronic kidney disease: Hydrogen sulfide offers a potential stinky remedy.
Dugbartey GJ
Pharmacol Rep; 2018 Apr; 70(2):196-205. PubMed ID: 29471067
[TBL] [Abstract][Full Text] [Related]
3. Involvement of hydrogen sulfide and homocysteine transsulfuration pathway in the progression of kidney fibrosis after ureteral obstruction.
Jung KJ; Jang HS; Kim JI; Han SJ; Park JW; Park KM
Biochim Biophys Acta; 2013 Dec; 1832(12):1989-97. PubMed ID: 23846016
[TBL] [Abstract][Full Text] [Related]
4. Gasotransmitters: Potential Therapeutic Molecules of Fibrotic Diseases.
Chen Y; Yuan S; Cao Y; Kong G; Jiang F; Li Y; Wang Q; Tang M; Zhang Q; Wang Q; Liu L
Oxid Med Cell Longev; 2021; 2021():3206982. PubMed ID: 34594474
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the Effect of Hydrogen Sulfide in the Idiopathic Pulmonary Fibrosis Model with a Fluorescent Probe.
Hou J; Huang Y; Fu L; Sun M; Wang L; Guo R; Chen L; Lv C
Anal Chem; 2023 Apr; 95(13):5514-5521. PubMed ID: 36943917
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen Sulfide: Recent Progression and Perspectives for the Treatment of Diabetic Nephropathy.
Sun HJ; Wu ZY; Cao L; Zhu MY; Liu TT; Guo L; Lin Y; Nie XW; Bian JS
Molecules; 2019 Aug; 24(15):. PubMed ID: 31390847
[TBL] [Abstract][Full Text] [Related]
7. Application of nintedanib and other potential anti-fibrotic agents in fibrotic diseases.
Liu F; Bayliss G; Zhuang S
Clin Sci (Lond); 2019 Jun; 133(12):1309-1320. PubMed ID: 31217321
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen Sulfide as a Potential Therapeutic Target in Fibrosis.
Zhang S; Pan C; Zhou F; Yuan Z; Wang H; Cui W; Zhang G
Oxid Med Cell Longev; 2015; 2015():593407. PubMed ID: 26078809
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen Sulfide Alleviates Peritoneal Fibrosis via Attenuating Inflammation and TGF-β1 Synthesis.
Lu Y; Gao L; Li L; Zhu Y; Wang Z; Shen H; Song K
Nephron; 2015; 131(3):210-9. PubMed ID: 26529331
[TBL] [Abstract][Full Text] [Related]
10. The Cardioprotective Effects of Hydrogen Sulfide in Heart Diseases: From Molecular Mechanisms to Therapeutic Potential.
Shen Y; Shen Z; Luo S; Guo W; Zhu YZ
Oxid Med Cell Longev; 2015; 2015():925167. PubMed ID: 26078822
[TBL] [Abstract][Full Text] [Related]
11. Carbamoylation abrogates the antioxidant potential of hydrogen sulfide.
Praschberger M; Hermann M; Laggner C; Jirovetz L; Exner M; Kapiotis S; Gmeiner BM; Laggner H
Biochimie; 2013 Nov; 95(11):2069-75. PubMed ID: 23896375
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen sulfide and cardioprotection--Mechanistic insights and clinical translatability.
Salloum FN
Pharmacol Ther; 2015 Aug; 152():11-7. PubMed ID: 25913517
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen sulfide protects against bleomycin-induced pulmonary fibrosis in rats by inhibiting NF-κB expression and regulating Th1/Th2 balance.
Cao H; Zhou X; Zhang J; Huang X; Zhai Y; Zhang X; Chu L
Toxicol Lett; 2014 Jan; 224(3):387-94. PubMed ID: 24269241
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide in renal physiology, disease and transplantation--the smell of renal protection.
Koning AM; Frenay AR; Leuvenink HG; van Goor H
Nitric Oxide; 2015 Apr; 46():37-49. PubMed ID: 25656225
[TBL] [Abstract][Full Text] [Related]
15. Emerging therapeutic interventions for idiopathic pulmonary fibrosis.
Chakraborty S; Chopra P; Ambi SV; Dastidar SG; Ray A
Expert Opin Investig Drugs; 2014 Jul; 23(7):893-910. PubMed ID: 24766571
[TBL] [Abstract][Full Text] [Related]
16. Notch in fibrosis and as a target of anti-fibrotic therapy.
Hu B; Phan SH
Pharmacol Res; 2016 Jun; 108():57-64. PubMed ID: 27107790
[TBL] [Abstract][Full Text] [Related]
17. The roles of hydrogen sulfide in renal physiology and disease states.
Feng J; Lu X; Li H; Wang S
Ren Fail; 2022 Dec; 44(1):1289-1308. PubMed ID: 35930288
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of cystathionine γ-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced inflammation in macrophage.
Wang XH; Wang F; You SJ; Cao YJ; Cao LD; Han Q; Liu CF; Hu LF
Cell Signal; 2013 Nov; 25(11):2255-62. PubMed ID: 23872072
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen Sulfide as a Novel Regulatory Factor in Liver Health and Disease.
Wu DD; Wang DY; Li HM; Guo JC; Duan SF; Ji XY
Oxid Med Cell Longev; 2019; 2019():3831713. PubMed ID: 30805080
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen sulfide and the liver.
Mani S; Cao W; Wu L; Wang R
Nitric Oxide; 2014 Sep; 41():62-71. PubMed ID: 24582857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
